TROG Cancer Research
Members Login   CQMS Login

News and Stories


An international study (BIG 3-07/TROG 07.01) shows that after breast conserving surgery, higher radiation doses to the part of the breast where the DCIS was found, in addition to radiotherapy of the whole breast, significantly reduced its risk of returning in patients with higher-risk DCIS.


The diagnosis of ductal carcinoma in situ (DCIS) of the breast has increased substantially due to mammographic screening, and now accounts for 25 per cent of screen-detected breast cancer. Over 1,600 women are diagnosed with DCIS in Australia every year. However, unlike invasive breast cancer, there are limited knowledge and experience for patients and clinicians to draw on when this now common diagnosis of DCIS is made.


Prostate cancer is one of the most common cancers amongst men, with one in six men diagnosed before their 85th birthday (Cancer Australia). In fact, in 2019 alone over 19,000 men in Australia were diagnosed with prostate cancer.


  COVID-19 and the regulations around social distancing has affected an increasing number of events across Australia, including the yearly gathering of radiation therapy experts at TROG Cancer Research’s Annual Scientific Meeting (ASM) Whilst ...


The coronavirus health pandemic is a challenging time for us all – personally and professionally. We know that the changes and safety precautions required as a result of the pandemic have had significant impacts on the way we ...


New research by the University of New South Wales (UNSW), presented at the Clinical Oncology Society of Australia’s (COSA) Annual Scientific Meeting (ASM) found that increased use of radiation therapy for prostate cancer patients could save ...


There is nothing scarier than hearing the words “you have cancer”. Unfortunately, more than 300 people in Australia hear these words every day and have to go through the difficult task of repeating them to loved ones, friends and even work colleagues.


Over three decades, TROG Cancer Research has facilitated hundreds of clinical trials that have involved more than 14,500 cancer patients and helped improve the outcome and quality of life for thousands more cancer patients globally. ...


TROG Cancer Research will work with clinicians at Townsville Hospital, as well as other national experts, to implement a research program aimed at understanding how to best use new MRI LINAC technology to benefit cancer patients. Weighing ...


TROG Cancer Research is currently in the final year of their 2017-2019 strategic plan. On Friday 2 August 2019, we held a strategic planning meeting with key stakeholders to discuss the direction and focus for the upcoming three years.


TROG Cancer Research are proud to announce that we have two new additions to the TROG Cancer Research Board of Directors.

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.